CELIVARONE (SSR149744C)
Sponsors
Sanofi
Conditions
Atrial FibrillationAtrial Flutter
Phase 2
Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr
CompletedNCT00232310
Start: 2005-10-31End: 2006-04-30Updated: 2012-05-08
Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter
CompletedNCT00233441
Start: 2004-12-31End: 2006-05-31Updated: 2012-05-08